{"id":"W2060057084","doi":"10.1182/blood-2011-04-351239","title":"Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Survivin; Cancer research; Chemotherapy; Drug resistance; Leukemia; Medicine; Minimal residual disease; Acute lymphocytic leukemia; Cytarabine; Drug; Inhibitor of apoptosis; Apoptosis; Biology; Pharmacology; Immunology; Lymphoblastic Leukemia; Internal medicine; Cancer; Programmed cell death","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001712146,0.0002554622,0.0005132112,0.0002898617,0.000105152,0.000407773,0.0002309101,0.0001723438,0.0005759828],"category_scores_gemma":[0.000180382,0.000123746,0.0001382474,0.0002193483,0.0001692304,0.0001886749,0.000209269,0.0005745266,0.0002470079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003748267,"about_ca_system_score_gemma":0.0002266247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005744217,"about_ca_topic_score_gemma":0.001407898,"domain_scores_codex":[0.9998583,0.0000269768,0.00001460635,0.00002083775,0.00004469672,0.00003455246],"domain_scores_gemma":[0.999939,0.000009484213,0.00001707356,0.000009782317,0.000007545267,0.00001715359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002655683,0.0002049945,0.0007091459,0.00008590389,0.0000195093,0.0001411946,0.00003484718,0.0005926269,0.9707017,0.0004751465,0.0002751096,0.02649425],"study_design_scores_gemma":[0.0002673185,0.003574794,0.006933562,0.00001610857,0.00009730824,0.001115626,0.00005695699,0.003950786,0.9674308,0.0002439407,0.01629969,0.00001300177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932034,0.002892416,0.001695727,0.0001558764,0.00004161957,0.00004375192,0.00006910175,0.0001685233,0.001729417],"genre_scores_gemma":[0.9959648,0.001608956,0.001051991,0.00005322647,0.00001389021,0.00002070493,0.000148411,0.00001601503,0.001122154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005759828,"threshold_uncertainty_score":0.002719522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01538796614368169,"score_gpt":0.2512861769358303,"score_spread":0.2358982107921486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}